Still Awaiting Approval by Chinese Agencies, BGI-Shenzhen Extends Offer for Complete Genomics | GenomeWeb

NEW YORK (GenomeWeb News) – BGI-Shenzhen said late on Wednesday that it has again extended its cash tender offer for Complete Genomics.

The offer is now set to expire midnight EST on Feb. 22. The extension is to allow China's Ministry of Commerce time to approve the deal and China's State Administration of Foreign Exchange to register the transaction, BGI said. It also noted the upcoming Chinese New Year holiday in China, which is set to begin Feb. 9 and end Feb. 15.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.